Ag-xcalcium

According to the FDA label: INDICATION & USAGE SECTION take two capsules once, two times a day

145,406 adverse event reports submitted to the FDA (1997–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Ag-x in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Ag-x adverse event reports by reporter sex
SexReports
Female105,735
Male29,958
Unknown126

By Age Group

View age group data as a table
Ag-x adverse event reports by reporter age group
Age groupReports
0-172,033
18-344,404
35-499,983
50-6428,485
65-7426,851
75+22,912

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Ag-x. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Ag-x adverse event reports by reported outcome
OutcomeReports
Other Serious62,654
Non-Serious55,890
Hospitalization39,820
Death10,083
Disability5,828
Life-Threatening5,379

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Ag-x. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Ag-x adverse event reports by year
YearReports
19971
20031
20042,119
200515
2006426
20071,224
20082,135
20093,113
20104,186
20112,863
20125,971
20136,373
20147,010
201512,039
201610,378
201710,876
201810,979
201910,243
202010,237
20219,734
20229,187
20238,495
20248,241
20257,955
2026 (partial)1,605

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Ag-x

In FDA adverse event reports that mention Ag-x, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026